Immediate Impact

2 by Nobel laureates 18 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
1 intermediate paper

Works of Joachim Blanz being referenced

Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors
2017
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
2013

Author Peers

Author Last Decade Papers Cites
Joachim Blanz 522 176 195 30 940
Indrasish Ray Chaudhuri 632 249 239 25 1.0k
Wen‐Hsing Lin 556 203 255 44 962
Sharon Diamond 340 302 180 21 1.0k
Yean Kee Lee 519 100 233 39 1.1k
J. Eileen Bird 304 198 159 38 1.0k
Anthony D. William 373 336 269 25 911
Michael A. Shirley 678 169 203 22 1.1k
Ravi S. Harapanhalli 398 123 199 27 1.1k
Kee Chuan Goh 588 149 387 26 1.1k
Yongying Jiang 411 150 161 39 861

All Works

Loading papers...

Rankless by CCL
2026